Novel long-acting degrader conjugates

TW202637219APending Publication Date: 2026-09-16ASCENDIS PHARM AS
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
TW114147849
Authority / Receiving Office
TW · TW
Patent Type
Applications
Current Assignee / Owner
Priority Date
2025-01-13
Filing Date
2025-12-05
Publication Date
2026-09-16
Patent Text Reader

Abstract

The present invention relates to a conjugate or a pharmaceutically acceptable salt thereof comprising at least one moiety -D, which is conjugated via at least one moiety -L1(-L2)a- to at least one moiety -Z, wherein -L1- is conjugated to -D, and wherein -D is a drug moiety comprising at least one receptor-binding moiety -RB and at least one target-binding moiety -TB; -L1- is a reversible linker moiety; -L2- is a spacer moiety; a is
Need to check novelty before this filing date? Find Prior Art